Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Accounts Payable: ¥842 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600479 Zhuzhou Qianjin Pharmaceutical Co Ltd SHSE:600479
71 GF Score
Price ¥9.93
GF Value ¥9.46
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Zhuzhou Qianjin Pharmaceutical Co Accounts Payable?

Zhuzhou Qianjin Pharmaceutical Co SHSE:600479 +0.30% 71 Accounts Payable is ¥842 Mil as of Mar. 2026. GuruFocus rates SHSE:600479 with a GF Score™ of 71/100 and a GF Value™ of ¥9.46 (Fairly Valued). The stock has 2 warning signs investors should review.

Zhuzhou Qianjin Pharmaceutical Co's Accounts Payable for the quarter that ended in Mar. 2026 was ¥842 Mil.

Zhuzhou Qianjin Pharmaceutical Co's quarterly Accounts Payable increased from Sep. 2025 (¥689 Mil) to Dec. 2025 (¥703 Mil) and increased from Dec. 2025 (¥703 Mil) to Mar. 2026 (¥842 Mil).

Zhuzhou Qianjin Pharmaceutical Co's annual Accounts Payable declined from Dec. 2023 (¥647 Mil) to Dec. 2024 (¥566 Mil) but then increased from Dec. 2024 (¥566 Mil) to Dec. 2025 (¥703 Mil).

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable Related Terms

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Zhuzhou Qianjin Pharmaceutical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable Chart

Zhuzhou Qianjin Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 511.67 780.92 647.49 565.64 702.98

Zhuzhou Qianjin Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 614.20 633.62 688.54 702.98 842.14
SHSE:600479
71GF Score
Zhuzhou Qianjin Pharmaceutical Co Ltd SHSE:600479
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ¥842 Mil mean?
Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) has a Accounts Payable of ¥842 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zhuzhou Qianjin Pharmaceutical Co and its competitors.
Is Zhuzhou Qianjin Pharmaceutical Co's Accounts Payable too high?
Zhuzhou Qianjin Pharmaceutical Co's current Accounts Payable is ¥842 Mil. Overall, Zhuzhou Qianjin Pharmaceutical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhuzhou Qianjin Pharmaceutical Co's Accounts Payable compare to ZTS?
Zhuzhou Qianjin Pharmaceutical Co's Accounts Payable of ¥842 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zhuzhou Qianjin Pharmaceutical Co and its competitors. Zhuzhou Qianjin Pharmaceutical Co's current Accounts Payable is ¥842 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhuzhou Qianjin Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) is currently considered Fairly Valued. The stock's GF Value™ is ¥9.46, compared to a current price of ¥9.93 — trading 5% above its estimated fair value. The current Accounts Payable is ¥842 Mil. Zhuzhou Qianjin Pharmaceutical Co's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479), the current Accounts Payable is ¥842 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Overvalued in 2026?

Based on GuruFocus' analysis, Zhuzhou Qianjin Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥9.93 is trading 5% above its estimated GF Value™ of ¥9.46. GuruFocus considers Zhuzhou Qianjin Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600479:

  • Accounts Payable: ¥842 Mil
  • GF Value™: ¥9.46 vs. price of ¥9.93 (5% above fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600479 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhuzhou Qianjin Pharmaceutical Co Business Description

Address No. 801, Zhuzhou Avenue, Tianyuan District, Hunan Province, Zhuzhou, CHN, 412000
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules. The company's products include Gynecological Qianjin Tablets (Capsules), Blood-Boosting Yimu Pills (Granules), Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin Meglumine Tablets, Entecavir Dispersible Tablets, Gynecological Special Cotton Towel Series, etc.
71GF Score

Get the complete analysis for SHSE:600479

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.93
Price
¥9.46
GF Value